Read some real life claim case studies.

Although pregnant women are at no greater risk of being infected by SARS-CoV-2, the woman and her infant are more likely to develop complications from COVID-19. Pregnant and lactating women were excluded from initial COVID-19 vaccine trials; thus, data to guide vaccine decision-making are lacking. Clinical trials evaluating the safety and efficacy of COVID-19 vaccines in pregnancy are now underway, and further trials are planned. The Vaccine Ministerial Advisory Committee (MAC) is continuously reviewing vaccine safety in pregnancy for all vaccines included in, or considered for inclusion, in the national vaccine rollout.

Please note that Bayer (Pty) Ltd is pleased to inform you that Angeliq® is back in stock. Bayer…

Click  HERE  to access the SASOG GMG Memorandum of Agreement with Respect to Coding Related Activities for Obstetricians…

Welcome to the new SASOG Council members: PRESIDENT: Dr Haynes Van Der Merwe HON SECRETARY: Dr Malikah…

Prof Greta Dreyer’s term office as President of SASOG has come to an end. Please find her…

]

HPCSA Fee increase 2021 Objection Final – Flow

Communication from the SASOG Medico-Legal Committee The Medico Legal Committee of SASOG has been, during the term…